Login to Your Account

Ziopharm Nabs Asian Partner for PTCL Drug Darinaparsin

By Jennifer Boggs

Tuesday, March 8, 2011
Ziopharm Oncology Inc. inked its first partnership for organic arsenic drug darinaparsin, signing a regional deal with Tokyo-based Solasia Pharma K.K. focused on specific Pan-Asian/Pacific territories.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription